In general, metastatic prostate cancer is managed medically. Here we present a patient with metastatic prostate cancer who was treated by surgical resection in addition to medical therapies. Local therapies should be considered if metastatic lesions are limited, also in cases of metastatic prostate cancer.
[1] Yokomizo Y, Kawahara T, Miyoshi Y et al. Efficacy of Immediate Switching from Bicalutamide to Flutamide as Second-Line Combined Androgen Blockade. Biomed Res Int 2016; 2016: 4083183
[2] European Association of Urology. Guidelines on Prostate Cancer. 2014: http://wwwuroweborg/gls/pdf/1607%20prostate%20Cancer_LRV3pd
[3] Bubendorf L, Schopfer A, Wagner U et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000; 31: 578 – 583
[4] Molenaar WM, Stoepker ME, de Ruiter AJ et al. Cytogenetic support for primary prostatic cancer in a patient presenting with a soft tissue mass in the leg. Cancer Genet Cytogenet 1996; 86: 147 – 149
[5] Ward AJ, Bourke JB. Skeletal muscle metastasis from prostatic carcinoma. J Urol 1984; 131: 769
[6] Gurel B, Ali TZ, Montgomery EA et al. NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol 2010; 34: 1097 – 1105
全国の大学の
卒論・修論・学位論文
を
一発検索！
論文の公開元へ